WallStreetZenWallStreetZen

NASDAQ: NMRD
Nemaura Medical Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for NMRD

Based on 2 analysts offering 12 month price targets for Nemaura Medical Inc.
Min Forecast
$7.50+257.14%
Avg Forecast
$7.75+269.05%
Max Forecast
$8.00+280.95%

Should I buy or sell NMRD stock?

Based on 2 analysts offering ratings for Nemaura Medical Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NMRD stock forecasts and price targets.

NMRD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$8.00+280.95%2022-08-19
EF Hutton
Bottom 1%
1
Strong BuyInitiates Coverage On$7.50+257.14%2021-12-02

1 of 1

Forecast return on equity

Is NMRD forecast to generate an efficient return?

Forecast return on assets

Is NMRD forecast to generate an efficient return on assets?
Company
-52.57%
Industry
10.83%
NMRD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NMRD earnings per share forecast

What is NMRD's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.64
Avg 2 year Forecast
-$0.43

NMRD revenue forecast

What is NMRD's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.6M+217.52%
Avg 2 year Forecast
$5.9M+1,070.85%
NMRD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NMRD revenue growth forecast

How is NMRD forecast to perform vs Medical Devices companies and vs the US market?
Company
242.18%
Industry
4.64%
Market
8.49%
NMRD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NMRD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NMRD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
NMRD$2.10$7.75+269.05%Strong Buy
ICCM$1.38$5.65+310.31%Strong Buy
SIEN$0.82$7.67+836.14%Strong Buy
DNAY$1.68$8.00+376.19%Strong Buy
TMDI$0.47N/AN/AHold

Nemaura Medical Stock Forecast FAQ

Is Nemaura Medical Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NMRD) stock is to Strong Buy NMRD stock.

Out of 2 analysts, 1 (50%) are recommending NMRD as a Strong Buy, 1 (50%) are recommending NMRD as a Buy, 0 (0%) are recommending NMRD as a Hold, 0 (0%) are recommending NMRD as a Sell, and 0 (0%) are recommending NMRD as a Strong Sell.

If you're new to stock investing, here's how to buy Nemaura Medical stock.

What is NMRD's earnings growth forecast for 2023-2024?

(NASDAQ: NMRD) Nemaura Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.09%.

Nemaura Medical's earnings in 2022 is -$14,522,377.On average, 1 Wall Street analyst forecast NMRD's earnings for 2023 to be -$15,425,834, with the lowest NMRD earnings forecast at -$15,425,834, and the highest NMRD earnings forecast at -$15,425,834.

In 2024, NMRD is forecast to generate -$10,364,232 in earnings, with the lowest earnings forecast at -$10,364,232 and the highest earnings forecast at -$10,364,232.

What is NMRD's revenue growth forecast for 2023-2024?

(NASDAQ: NMRD) Nemaura Medical's forecast annual revenue growth rate of 242.18% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.64%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.49%.

Nemaura Medical's revenue in 2022 is $503,906.On average, 1 Wall Street analysts forecast NMRD's revenue for 2023 to be $38,564,586, with the lowest NMRD revenue forecast at $38,564,586, and the highest NMRD revenue forecast at $38,564,586.

In 2024, NMRD is forecast to generate $142,206,909 in revenue, with the lowest revenue forecast at $142,206,909 and the highest revenue forecast at $142,206,909.

What is NMRD's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: NMRD) forecast ROA is -52.57%, which is lower than the forecast US Medical Devices industry average of 10.83%.

What is NMRD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NMRD price target, the average NMRD price target is $7.75, with the highest NMRD stock price forecast at $8.00 and the lowest NMRD stock price forecast at $7.50.

On average, Wall Street analysts predict that Nemaura Medical's share price could reach $7.75 by Aug 19, 2023. The average Nemaura Medical stock price prediction forecasts a potential upside of 269.05% from the current NMRD share price of $2.10.

What is NMRD's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: NMRD) Nemaura Medical's current Earnings Per Share (EPS) is -$0.62. On average, analysts forecast that NMRD's EPS will be -$0.64 for 2023, with the lowest EPS forecast at -$0.64, and the highest EPS forecast at -$0.64. In 2024, NMRD's EPS is forecast to hit -$0.43 (min: -$0.43, max: -$0.43).

What is NMRD's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: NMRD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.